Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-07-29

Clinical Trial Update: Efficacy and Safety of Therapy With Tri-Luma® Cream in Sequence With Glycolic Acid Peels for Melasma [Phase 4]

View source ↗

Summary

Phase 4 trial assessing efficacy and safety of Tri-Luma Cream used in sequence with glycolic acid peels for melasma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Tri-Luma Cream

Snippet

Sponsor: Galderma R&D | Conditions: Melasma | Phase 4 | Status: COMPLETED